| NP0350751 | Bipoladisin D | |  | C25H34O3
382.5440 Da 382.25079 Da | | 1H NMR Spectrum (1D, 400.132470967, CDCl3, simulated) | | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) |
|
| NP0350750 | Bipoladisin C | |  | C25H36O4
400.5590 Da 400.26136 Da | | 1H NMR Spectrum (1D, 400.132470967, CDCl3, simulated) | | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) |
|
| NP0350749 | Bipoladisin B | |  | C29H45NO7
519.6790 Da 519.31960 Da | | 1H NMR Spectrum (1D, 400.132470967, CDCl3, simulated) | | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) |
|
| NP0350748 | Bipoladisin A | |  | C27H41NO6
475.6260 Da 475.29339 Da | | 1H NMR Spectrum (1D, 400.132470967, CDCl3, simulated) | | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) |
|
| NP0350747 | 11,13-Dehydrolanuginolide | |  | C17H22O5
306.3580 Da 306.14672 Da | |
| NP0350746 | Epoxylaurenobiolide | |  | C17H22O5
306.3580 Da 306.14672 Da | |
| NP0350745 | Nanamin B | |  | C42H52N8O11S
876.9800 Da 876.34763 Da | | 1H NMR Spectrum (1D, 700.164323488, C2D6OS, simulated) | | 1H NMR Spectrum (1D, 700 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 176 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) |
|
| NP0350744 | alstolarsine E | |  | C22H24N2O5
396.4430 Da 396.16852 Da | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
| NP0350743 | alstolarsine D | |  | C22H24N2O4
380.4440 Da 380.17361 Da | | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) |
|
| NP0350742 | alstolarsine C | |  | C22H24N2O4
380.4440 Da 380.17361 Da | | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) |
|
| NP0350741 | alstolarsine B | |  | C23H26N2O4
394.4710 Da 394.18926 Da | | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) |
|
| NP0350740 | alstolarsine A | |  | C23H26N2O4
394.4710 Da 394.18926 Da | | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) |
|
| NP0350738 | 1H-Benz[e]indene-3-butyric acid, 7-carboxy-6-(2-carboxyethyl)dodecahydro-γ-hydroxy-γ,6,9a,9b-tetramethyl-, γ-lactone, 6-methyl ester | |  | C26H40O6
448.6000 Da 448.28249 Da | | 1H NMR Spectrum (1D, 700 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 176 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 700 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 700 MHz, CDCl3, experimental) |
|
| NP0350737 | 2′′′,5′′′-Diepisilvestrol | |  | C34H38O13
654.6650 Da 654.23124 Da | | 1H NMR Spectrum (1D, 700 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 176 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, CDCl3, experimental) |
|
| NP0350736 | 2′′′-Episilvestrol | |  | C34H38O13
654.6650 Da 654.23124 Da | | 1H NMR Spectrum (1D, 700 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 176 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, CDCl3, experimental) |
|
| NP0350735 | Episilvestrol (5′′′-episilvestrol) | |  | C34H38O13
654.6650 Da 654.23124 Da | | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) |
|
| NP0350734 | Silvestrol acetonide | |  | C37H42O13
694.7300 Da 694.26254 Da | | 1H NMR Spectrum (1D, 700 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 176 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, CDCl3, experimental) |
|
| NP0350733 | Episilvestrol acetonide | |  | C37H42O13
694.7300 Da 694.26254 Da | | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) |
|
| NP0350732 | Chromonemycin D | |  | C20H18O7
370.3570 Da 370.10525 Da | | 1H NMR Spectrum (1D, 500.112750605, C2D6OS, simulated) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) |
|
| NP0350731 | Chromonemycin C | |  | C20H18O7
370.3570 Da 370.10525 Da | | 1H NMR Spectrum (1D, 500, C2D6OS, simulated) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) |
|
| NP0350730 | Chromonemycin B | |  | C20H18O8
386.3560 Da 386.10017 Da | | 1H NMR Spectrum (1D, 500, C2D6OS, simulated) | | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) |
|
| NP0350729 | Chromonemycin A | |  | C20H16O7
368.3410 Da 368.08960 Da | | 1H NMR Spectrum (1D, 500.112750605, C2D6OS, simulated) | | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) |
|
| NP0350728 | (−)-Feionemycin A | |  | C19H14O5
322.3160 Da 322.08412 Da | | 1H NMR Spectrum (1D, 500, C2D6OS, simulated) | | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) |
|
| NP0350727 | (+)-Feionemycin A | |  | C19H14O5
322.3160 Da 322.08412 Da | | 1H NMR Spectrum (1D, 500, C2D6OS, simulated) | | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) |
|
| NP0350726 | Martensiiagm G | |  | C13H17N5O
259.3130 Da 259.14331 Da | |